Key Highlights

  • SK1 shares rose 2.06% to $2.48, up 0.050 on the day
  • Pro forma Revenue up 29 percent to $90.2 million, ahead of Prospectus forecast
  • Pro forma net profit up 41 percent to $9.0 million, 5 percent ahead of forecast
  • Store network grew to 109 stores, one ahead of forecast
  • Like-for-like revenue growth of 9.6 percent, ahead of the 8.1 percent forecast

SkinKandy Limited (ASX:SK1) shares were trading 2.06% higher at AUD 2.48, up 0.050 on the day, as at 3:05pm AEST on 25 August 2026, after the specialty piercing and jewellery retailer's first results as an ASX-listed company beat forecasts set out in its Prospectus. Pro forma revenue increased 29 percent to $90.2 million, 2 percent ahead of forecast, while pro forma net profit after tax rose 41 percent to $9.0 million, 5 percent ahead of forecast.

Why SkinKandy Shares Are Higher Today

The gain follows a clean beat against IPO Prospectus targets across every key metric:

  • Pro forma revenue: $90.2 million, up 29 percent, 2 percent ahead of forecast
  • Pro forma NPAT: $9.0 million, up 41 percent, 5 percent ahead of forecast
  • Pro forma EBITDA: $24.6 million, up 41 percent, 5 percent ahead of forecast
  • Store network: 109 stores after 22 openings, one ahead of the 108 forecast
  • Like-for-like revenue growth: 9.6 percent, ahead of the 8.1 percent forecast

Margins and Balance Sheet

  • Pro forma gross margin: 89.2 percent, in line with forecast
  • Cost of doing business: 62 percent of revenue, down from 65 percent
  • Pro forma EBIT margin: 15.3 percent, up from 14.1 percent
  • Cash reserves: $13.8 million, no drawn debt
  • Net assets: $44.5 million, up from $30.5 million

FY27 Trade Update

  • First 7 weeks of FY27: unaudited revenue up 22 percent on the prior year
  • Gross Margin consistent with FY26 levels
  • Store count grown to 114 since period end, with 12 more leases approved for FY27
  • Targeting 18 to 20 new store openings in FY27, plus entry into a market beyond Australia and New Zealand

What's Supporting the Stock

As SkinKandy's first results since its May 2026 IPO, the beat across revenue, profit and store growth appears to be building investor confidence in the company's rollout strategy, with trading momentum continuing into the early weeks of FY27 supporting today's share price gain.